[go: up one dir, main page]

SI2182954T1 - Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze - Google Patents

Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze

Info

Publication number
SI2182954T1
SI2182954T1 SI200832036T SI200832036T SI2182954T1 SI 2182954 T1 SI2182954 T1 SI 2182954T1 SI 200832036 T SI200832036 T SI 200832036T SI 200832036 T SI200832036 T SI 200832036T SI 2182954 T1 SI2182954 T1 SI 2182954T1
Authority
SI
Slovenia
Prior art keywords
arteriosclerosis
treatment
bile acids
bile
acids
Prior art date
Application number
SI200832036T
Other languages
English (en)
Inventor
Moustafa Tarek
Michael Trauner
Peter Fickert
Original Assignee
Medizinische Universitat Graz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinische Universitat Graz filed Critical Medizinische Universitat Graz
Publication of SI2182954T1 publication Critical patent/SI2182954T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SI200832036T 2007-07-25 2008-07-24 Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze SI2182954T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95172807P 2007-07-25 2007-07-25
EP07113107 2007-07-25
EP08775321.6A EP2182954B1 (en) 2007-07-25 2008-07-24 Use of nor-bile acids in the treatment of arteriosclerosis
PCT/EP2008/059704 WO2009013334A1 (en) 2007-07-25 2008-07-24 Use of nor-bile acids in the treatment of arteriosclerosis

Publications (1)

Publication Number Publication Date
SI2182954T1 true SI2182954T1 (sl) 2019-04-30

Family

ID=39744896

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200832036T SI2182954T1 (sl) 2007-07-25 2008-07-24 Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze

Country Status (7)

Country Link
US (2) US20100311708A1 (sl)
EP (1) EP2182954B1 (sl)
ES (1) ES2709489T3 (sl)
PT (1) PT2182954T (sl)
SI (1) SI2182954T1 (sl)
TR (1) TR201901012T4 (sl)
WO (1) WO2009013334A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468762A1 (en) 2010-11-30 2012-06-27 Dr. Falk Pharma Gmbh Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
EP3461485A1 (en) * 2017-09-28 2019-04-03 Dr. Falk Pharma Gmbh Use of nor-ursodeoxycholic acid for reducing liver fat
WO2021130232A1 (en) 2019-12-23 2021-07-01 Medizinische Universität Wien Bile acid derivatives in the medical intervention of anxieties and/or stress symptoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892868A (en) * 1984-08-17 1990-01-09 Gipharmex, S.P.A. Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
IT1255449B (it) * 1992-06-30 1995-10-31 Fabio Berlati Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TW289020B (sl) * 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
US7312208B2 (en) * 2002-08-28 2007-12-25 Asahi Kasei Pharma Corporation Quaternary ammonium compounds
PT2392335E (pt) * 2005-05-12 2015-10-06 Medizinische Universität Graz Utilização de 24-norudca
US20070116755A1 (en) * 2005-11-22 2007-05-24 Zadini Filiberto P Dissolution of arterial cholesterol plaques by pharmacological preparation

Also Published As

Publication number Publication date
WO2009013334A1 (en) 2009-01-29
US20100311708A1 (en) 2010-12-09
ES2709489T3 (es) 2019-04-16
US20200101084A1 (en) 2020-04-02
EP2182954A1 (en) 2010-05-12
EP2182954B1 (en) 2018-11-28
PT2182954T (pt) 2019-02-06
TR201901012T4 (tr) 2019-02-21

Similar Documents

Publication Publication Date Title
PL1978947T3 (pl) Nitrooksypochodne do zastosowania w leczeniu dystrofii mięśniowych
HK1148284A1 (en) Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions hif
GB0803018D0 (en) Therapeutic compounds and their use
PL1912650T3 (pl) Zastosowanie flibanseryny w leczeniu otyłości
GB0804685D0 (en) Therapeutic compounds and their use
EP2185202A4 (en) USE OF INTERLEUKIN-22 FOR THE TREATMENT OF FATTLEBER
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
ZA201002764B (en) Benzodiazepinone compounds useful in the treatment of skin conditions
GB0807609D0 (en) Therapeutic compounds and their use
GB0817208D0 (en) Therapeutic apsap compounds and their use
EP2307052A4 (en) ANTI-BETA-2-MICROGLOBULIN AGENTS AND THEIR USE
HK1209053A1 (zh) 地來西坦在慢性疼痛的治療中的用途
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
HK1143756A1 (en) Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
GB0822486D0 (en) Compounds for use in the treatment of pain
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
SI2491005T1 (sl) Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja
SI2182954T1 (sl) Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
GB0812913D0 (en) Therapeutic compounds and their use
GB0821594D0 (en) Improvements in or relating to the treatment of tissue damage
GB0802128D0 (en) Therapeutic compounds and their use
HK1173995A1 (en) Use of ferroquine in the treatment of malaria
GB0815134D0 (en) Therapeutic compounds and their use
GB0725166D0 (en) The use of ketoprofen in treating hemorrhoids